Sukel, Myrthe P P <br/><br/>
Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal.  [electronic resource] 

 -  Pharmacoepidemiology and drug safety  Jan 2008 
 - 9-19 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1053-8569 
<br/><br/><label>Standard No.: </label>10.1002/pds.1508  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Arthritis, Rheumatoid--drug therapy<br/>Cardiovascular Diseases--prevention & control<br/>Cohort Studies<br/>Cyclooxygenase 2 Inhibitors--administration & dosage<br/>Databases, Factual<br/>Drug Prescriptions--statistics & numerical data<br/>Drug Therapy, Combination<br/>Drug Utilization Review<br/>Drug and Narcotic Control<br/>Female<br/>Gastrointestinal Diseases--chemically induced<br/>Humans<br/>Lactones--administration & dosage<br/>Male<br/>Middle Aged<br/>Practice Patterns, Physicians'--statistics & numerical data<br/>Proton Pump Inhibitors<br/>Sulfones--administration & dosage